Immune Pharma appoints Tony Fiorino as COO
Dr. Fiorino brings to the Company a unique background and specialized expertise, which includes extensive experience in medical affairs, drug development and biotechnology finance and operations.
Dr. Fiorino joins the Company from Triumvira Immunologics, an immuno-oncology company developing a novel engineered T cell platform, where he served as President and Chief Executive Officer.
Prior to joining Triumvira, Dr. Fiorino was the Chief Executive Officer of BrainStorm Cell Therapeutics.
Prior to joining BrainStorm, he was the Founder, President and CEO of EnzymeRx.
Before founding EnzymeRx, Dr. Fiorino worked as a biotechnology and pharmaceuticals analyst and portfolio manager at firms including JP Morgan, Citigroup, and Pequot Capital.
Dr. Fiorino earned an MD and a PhD from the Albert Einstein College of Medicine, where he studied the differentiation of liver progenitor cells, and a BS from the Massachusetts Institute of Technology. ■
LATEST MOVES FROM Israel
- Teva appoints Kåre Schultz as CEO
- Enzymotec appoints Dror Israel as CFO
- Intec Pharma appoints Jeffrey A. Meckler as CEO
- Foamix Pharmaceuticals names David Domzalski as CEO
- Compugen appoints Michal Preminger as director
More inside POST